Novel Materials and Technologies for Controlled Drug Delivery Systems
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: closed (20 June 2024) | Viewed by 2187
Special Issue Editor
Interests: nanotechnology; lipid-based drug delivery systems; natural antioxidants; transdermal delivery systems; semisolid formulations
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The control of therapeutics represents a crucial point in modern pharmaceutics. Indeed, the smart delivery of drugs enables prolonged drug release to achieve specific targets and/or to overcome biological barriers. As a matter of fact, conventional pharmaceutical forms, such as solutions, suspensions, emulsions, tablets, and capsules, often lead to scarce drug bioavailability, while hindering the achievement of sustained release, resulting in an irregular plasma drug level. Moreover, to ensure maximum efficacy and safety, the drug should be delivered specifically at the target site. In this respect, recent research progress has led to the development of new controlled drug delivery systems, ranging from the macro to nano scale, including smart drug delivery systems suitable to obtain targeted delivery. This Special Issue aims to showcase recent findings about novel drug delivery systems designed for different administration routes, including transdermal and nasal ones. Notably, the use of innovative production methodologies, such as microfluidics and 3D printing, is particularly appreciated from the perspective of industrial scaling-up and applications.
Dr. Elisabetta Esposito
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- smart drug delivery systems
- nanoparticles
- 3D printing
- microfluidics
- transdermal delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
